Feng Li

Feng Li is a biopharma expert currently serving as the Director of Drug Product Tech Transfer at AstraZeneca. With extensive experience in viral vaccine and vector development, mAb technologies, and sterile injectables, Feng has held various roles including Senior Scientist at Johnson & Johnson and MSAT Director at WuXi Biologics. Feng completed a PhD at Wageningen University, focusing on protein-based hydrogels, and previously contributed to research and innovation as a Postdoc at TU Delft and as a Research Scientist at DSM. Throughout their career, Feng has built connections between global technology and market needs, driving business growth and advancing drug product development.